Showing results (271-280 of 294) with videos related to

Sort By:
Pageof 30
The Lancet. Gastroenterology & Hepatology|May 3, 2026
The use of pharmacotherapies in non-cirrhotic metabolic dysfunction-associated steatohepatitis: a UK expert consensusJeremy F Cobbold, Hamish Miller, Kate Hallsworth, et al.
Hepatology (Baltimore, Md.)|February 27, 2022
Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profilesIbon Martínez-Arranz, Chiara Bruzzone, Mazen Noureddin, et al.
The American Journal of Gastroenterology|September 2, 2020
Obesity, Diabetes, Coffee, Tea, and Cannabis Use Alter Risk for Alcohol-Related Cirrhosis in 2 Large Cohorts of High-Risk DrinkersJohn B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|April 4, 2024
Diagnostic accuracy of non-invasive tests to screen for at-risk MASH-An individual participant data meta-analysisFerenc E Mózes, Jenny A Lee, Yasaman Vali, et al.
Gastroenterology|May 8, 2020
Liver Phenotypes of European Adults Heterozygous or Homozygous for Pi∗Z Variant of AAT (Pi∗MZ vs Pi∗ZZ genotype) and NoncarriersCarolin V Schneider, Karim Hamesch, Annika Gross, et al.
Hepatology (Baltimore, Md.)|August 4, 2023
A global action agenda for turning the tide on fatty liver diseaseJeffrey V Lazarus, Henry E Mark, Alina M Allen, et al.
Alcohol (Fayetteville, N.Y.)|December 27, 2017
Evaluation of laboratory tests for cirrhosis and for alcohol use, in the context of alcoholic cirrhosisJohn B Whitfield, Steven Masson, Suthat Liangpunsakul, et al.
Nature Genetics|May 18, 2026
Integrated multi-omics identifies distinct macrophage alterations during progression of metabolic dysfunction-associated steatohepatitisMarkus Boesch, Seray Anak, Dania El Abyad, et al.
Hepatology (Baltimore, Md.)|August 28, 2020
Genome-wide Association Study and Meta-analysis on Alcohol-Associated Liver Cirrhosis Identifies Genetic Risk FactorsTae-Hwi Schwantes-An, Rebecca Darlay, Philippe Mathurin, et al.
Contemporary Clinical Trials|October 6, 2023
Liver Investigation: Testing Marker Utility in Steatohepatitis (LITMUS): Assessment & validation of imaging modality performance across the NAFLD spectrum in a prospectively recruited cohort study (the LITMUS imaging study): Study protocolMichael Pavlides, Ferenc E Mózes, Salma Akhtar, et al.
Pageof 30